The world’s first biotechnology company to deliver long-term health hazard assessment without the use of animals.
Alternative to animal testing
Using our cellular sensory devices we provide you with a valuable alternative to animal testing and target the toxicological safety testing of nanomaterials.
INFINITE-μIND technology addresses the efforts of policymakers and regulators to eliminate animal testing and introduce alternative methods.
Scientific background
Infinite's unique idea relies on the recent breakthroughs in molecular event detection, photonics and stem cell technologies.
Affordable for everyone
Toxicity testing has so far been affordable to almost exclusively large companies, as animal testing is expensive and time-consuming.
Our service is affordable for every company. It is intended primarily for companies that care whether their employees or end users are exposed to hazardous powdered forms of materials.
With INFINITE-µIND technology
INFINITE-µIND enables in silico prediction of the development of long-term disease symptoms arising from inhalation of hazardous materials based on in vitro detection of early molecular events in a living cellular system that mimics lung function.
INFINITE-µIND technology is based on recent discoveries about the triggering of long-term inflammatory conditions and their prediction without the use of test animals.
With advanced biophysical and molecular-biological methods, early molecular events within cells can be observed much earlier than the development of symptoms at the organism level.
based on the latest findings on disease triggering mechanisms.
based on the detection of recently discovered early molecular events and a mechanistic model.
using a cellular sensory system and advanced microscopy technologies.
due to low cost, speed, sensitivity of detection and flexibility of testing.
based on low cost, speed, sensitivity of detection and flexibility of testing.
because animal testing is no longer needed.
by supporting the efforts of regulators in the introduction of 3R alternative technologies (replace, reduce, refine).
based on the latest findings on disease triggering mechanisms.
Our INFINITE-µIND technology enables high throughput long-term health hazard assessment by in finite cellular processing.
Our development stems from large collaborative effort of scientists from all over Europe, culminated in the work published in the journal of Advanced Materials proving the feasibility to predict long-term health hazards from in vitro observations.
Soon our discovery triggered a rush of media responses by many regulators and experts from all around the world, including being highlighted by the European Commission.
From 2020
"Secure your future and let our tiny living sensory devices keep an eye on your biosafety."